Policy | May 09, 2023
Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
The Theme of the event was 'Building One Health Together – Improving Health Equity'
Subscribe To Our Newsletter & Stay Updated
